DARE · Company research

Dare Bioscience, Inc. Common Stock (DARE): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Daré Bioscience, Inc. (DARE) stock price, news, quote and history - Yahoo Finance UKDaré Bioscience, Inc. (DARE) stock price, news, quote and history Yahoo Finance UKView source ↗Yahoo Finance UKOct 14, 2026neutral00.6
Daré Bioscience, Inc. (DARE) Stock Price, News, Quote & History - Yahoo! Finance CanadaDaré Bioscience, Inc. (DARE) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 9, 2026neutral00.6
Daré Bioscience, Inc. (DARE) stock price, news, quote and history - Yahoo Finance SingaporeDaré Bioscience, Inc. (DARE) stock price, news, quote and history Yahoo Finance SingaporeView source ↗Yahoo Finance SingaporeOct 9, 2026neutral00.6
Daré Bioscience Inc Share Price - DARE, RNS News, Articles, Quotes, & Charts (NASDAQ:DARE) - Proactive financial newsDaré Bioscience Inc Share Price - DARE, RNS News, Articles, Quotes, & Charts (NASDAQ:DARE) Proactive financial newsView source ↗Proactive financial newsOct 6, 2026neutral00.6
Dare Bioscience stock rises after receiving HPV treatment patent By Investing.com - Investing.com South AfricaDare Bioscience stock rises after receiving HPV treatment patent By Investing.com Investing.com South AfricaView source ↗Investing.com South AfricaSep 28, 2026neutral00.6
Dare Bioscience stock rises after receiving HPV treatment patent - Investing.comDare Bioscience stock rises after receiving HPV treatment patent Investing.comView source ↗Investing.comSep 28, 2026neutral00.6
About 6 million U.S. women face high-risk HPV yearly, with no approved drug treatment. - Stock TitanAbout 6 million U.S. women face high-risk HPV yearly, with no approved drug treatment. Stock TitanView source ↗Stock TitanSep 28, 2026neutral00.6
Warrants covering about 45% of existing shares await a vote at Daré Bioscience (NASDAQ: DARE). - Stock TitanWarrants covering about 45% of existing shares await a vote at Daré Bioscience (NASDAQ: DARE). Stock TitanView source ↗Stock TitanSep 23, 2026neutral00.6
A women’s health biotech launches one product while preparing another to generate revenue - Stock TitanA women’s health biotech launches one product while preparing another to generate revenue Stock TitanView source ↗Stock TitanAug 25, 2026neutral00.6
H.C. Wainwright reiterates Dare Bioscience stock rating at buy - Investing.comH.C. Wainwright reiterates Dare Bioscience stock rating at buy Investing.comView source ↗Investing.comAug 17, 2026neutral00.6
Daré Bioscience Announces $6.0 Million Registered Direct Offering and Concurrent Private Placement - Quiver QuantitativeDaré Bioscience Announces $6.0 Million Registered Direct Offering and Concurrent Private Placement Quiver QuantitativeView source ↗Quiver QuantitativeAug 14, 2026neutral00.6
Daré Bioscience, Inc. (NASDAQ:DARE): Are Analysts Optimistic? - Simply Wall StreetDaré Bioscience, Inc. (NASDAQ:DARE): Are Analysts Optimistic? Simply Wall StreetView source ↗Simply Wall StreetJul 21, 2026neutral00.6
Market Movers | Winners: ADVB, LVLU, ONCO | Losers: QMLS, DARE, PLAG - TrefisMarket Movers | Winners: ADVB, LVLU, ONCO | Losers: QMLS, DARE, PLAG TrefisView source ↗TrefisJul 21, 2026neutral00.6
Dare Bioscience Received Notice of Delisting - TradingViewDare Bioscience Received Notice of Delisting TradingViewView source ↗TradingViewJul 17, 2026neutral00.6
DARE Forecast — Price Target — Prediction for 2027 - TradingViewDARE Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswireDaré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update GlobeNewswireView source ↗GlobeNewswireMay 14, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.